Journal of Pediatric Care

Long term outcomes of patients diagnosed with PANDAS (Pediatric Autoimmune Neuropsychiatric Disorder associated with group A Streptococcus - a 17 years prospective clinical study

EuroSciCon Conference on Pediatrics 2017
November 13-14, 2017 London, UK

Miroslav Kovacevic

University of Illinois at Chicago College of Medicine, USA

Posters & Accepted Abstracts: J Pediatr Care

DOI: 10.21767/2471-805X-C1-003

Abstract

PANDAS as a distinct clinical entity has been a source of controversies from its initiation in 1996-1998. In recent years (2010 until now) it has been receiving wide attention in scientific publications and it has been finally accepted as a valid clinical diagnosis. The purpose of this presentation is to review current diagnostic and therapeutic protocols applicable to PANDAS and to report on long term outcomes of patients receiving the recommended treatment(s). Although most medical literature reports to date address pediatric population affected by this syndrome specifically, this report also addresses incidence, diagnostic and therapeutic protocols for adolescents and young adults with PANDAS. Consequently, it appears that in a specific cohort of adolescent and young adult population diagnosed with PANDAS treatments otherwise used in children may indeed be an effective therapeutic alternative